Adenosine Triphosphate (ATP) Swab Test Market Forecast and Growth 2031

Adenosine Triphosphate (ATP) Swab Test Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis  Report Coverage: By Type (Free ATP Test and Microbial ATP Test) and Application (Pharmaceutical and Biotechnology Companies, Food and Beverage, Hospitals and Diagnostics Laboratories, and Academic and Research Institutions), and Geography

  • Report Code : TIPRE00014433
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Adenosine Triphosphate (ATP) Swab Test Market Size | 2031

Buy Now

The Adenosine Triphosphate (ATP) Swab Test Market size was estimated to be US$ 229.33 million in 2021 and US$ XX million in 2023 and is expected to reach US$ 535.16 million by 2031; it is estimated to record a CAGR of 9.2% in till 2031. Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System is likely to remain key Adenosine Triphosphate (ATP) Swab Test Market trends.

Adenosine Triphosphate (ATP) Swab Test Market Analysis

Rising prevalence of Healthcare-Associated Infections (HAIs) is one of the prominent factors, which is driving the demand for Adenosine Triphosphate (ATP) Swab Test. For instance, the World Health Organization (WHO), launched the first-ever global report on Infection Prevention and Control in May 2022. The report states that out of every 100 patients admitted to acute-care hospitals, 7 patients in high-income countries and 15 patients in low- and middle-income countries are at risk of acquiring at least one HAIs during their hospital stay. On average, 1 in every ten affected patients will die from their HAIs. Such substantial prevalence of HAIs is anticipated to have a positive impact on the adoption of ATP swab test driving the growth of Adenosine Triphosphate (ATP) Swab Test market.

Adenosine Triphosphate (ATP) Swab Test Market Overview

The growth of the Adenosine Triphosphate (ATP) Swab Test market is attributed to some key driving factors such as rising prevalence of HAIs and increasing emphasis on food safety. However, limitations of ATP swab tests is a major factor hindering the market growth. Global Adenosine Triphosphate (ATP) swab test market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the US is the largest market for ATP swab tests. The growth of the region is attributed to presence of key market players and rising prevalence of HAIs. In addition, continuous product developments is further expected to stimulate the growth of Adenosine Triphosphate (ATP) swab test market in North America.

The Asia Pacific region is expected to account for the fastest growth in the Adenosine Triphosphate (ATP) swab test market. The rapid growth in the healthcare and food & beverage industry and increased investments and innovations in the hygiene monitoring system by major market players in Asia Pacific for their geographical expansion and other strategies is likely to fuel the growth of the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Adenosine Triphosphate (ATP) Swab Test Market: Strategic Insights

Adenosine Triphosphate (ATP) Swab Test Market

  • CAGR (2023 - 2031)
    9.2%
  • Market Size 2021
    US$ 229.33 Million
  • Market Size 2031
    US$ 535.16 Million

Market Dynamics

GROWTH DRIVERS
  • Rising prevalence of Healthcare-Associated Infections (HAIs) have a positive impact on the adoption of ATP swab test driving the growth of Adenosine Triphosphate (ATP) Swab Test market
  • Rising Incidence of Foodborne Diseases and Food Contamination to Favor Adenosine Triphosphate (ATP) Market  
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • Growing initiatives on Patient Safety and Care is attractive growth opportunity for the Adenosine Triphosphate (ATP) swab test market

Key Players

  • Hygiena, Llc
  • 3M
  • Charm Sciences, Inc.
  • Kikkoman Biochemifa
  • Neogen
  • Ecolab
  • Ruhof Healthcare Corporation
  • Luminultra Technologies Ltd.
  • Merck KgaA
  • Promega Corporation

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Free ATP Test
  • Microbial ATP Test
Application
  • Pharmaceutical and Biotechnology Companies
  • Food and Beverage
  • Hospitals and Diagnostics Laboratories
  • Academic and Research Institutions
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Adenosine Triphosphate (ATP) Swab Test Market Drivers and Opportunities

Rising Incidence of Foodborne Diseases and Food Contamination to Favor Market

According to the WHO, unsafe food is responsible for causing 600 million cases of foodborne diseases and 420,000 deaths every year globally. Children under five years of age account for 30% of these deaths. Furthermore, WHO estimates that globally, 33 million years of healthy lives are lost annually due to consuming unsafe food, and this number is likely an underestimation. Consuming food contaminated with bacteria, viruses, parasites, or chemical substances like heavy metals can cause over 200 different diseases, contributing significantly to disease burden and mortality worldwide. ATP testing is especially crucial in food production environments. If food isn't cleaned up correctly, it can promote the growth of microbes. Food can also serve as a source of nutrients for bacteria, mould, and yeast, which can lead to their growth. Therefore, ATP testing can be used to provide an early warning system and to ensure that food environments are appropriately hygienic. Such substantial prevalence of foodborne diseases and conditions is boosting the need for food safety. This need is likely to drive the ATP swab test market during the forecast period

Growing initiatives on Patient Safety and Care – An Opportunity in Customisation of Adenosine Triphosphate (ATP) Swab Test Market

HAIs are one of the prominent causes for substantial mortality and illness amongst hospital patients. In addition, these conditions lead to additional financial and emotional burden on patients as well as healthcare systems across the globe. Therefore, the government and healthcare authorities are emphasizing on implementation of safety programs to prevent healthcare-associated infections. For instance, In 2019, the Seventy-second World Health Assembly passed a resolution (WHA72.6) on “Global action on patient safety”, mandating the development of a global patient safety action plan. The Global Patient Safety Action Plan for the decade 2021-2030 provides a comprehensive framework for stakeholders to join efforts and implement patient safety initiatives in a coordinated manner.  Implementation of such policies are estimated to generate attractive growth opportunity for the Adenosine Triphosphate (ATP) swab test market.

Adenosine Triphosphate (ATP) Swab Test Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Adenosine Triphosphate (ATP) Swab Test Market analysis are type, and application.

  • Based on type, the Adenosine Triphosphate (ATP) Swab Test market is bifurcated into Free ATP Test and Microbial ATP Test. The Free ATP test segment held a larger market share in 2023.
  • In terms of application, the market is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostics laboratories, and academic and research institutions. The pharmaceutical and biotechnology companies segment dominated the market in 2023.

Adenosine Triphosphate (ATP) Swab Test Market Share Analysis by Geography

The geographic scope of the Adenosine Triphosphate (ATP) Swab Test Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the Adenosine Triphosphate (ATP) Swab Test Market. The Centers for Disease Control (CDC) estimates that in American hospitals, HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year. The growth in North America is characterized by the growing burden of HAIs is expected to boost Adenosine Triphosphate (ATP) Swab Test Market demand. Similarly, increasing incidence of foodborne diseases and food contamination are equally influencing the market's growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Adenosine Triphosphate (ATP) Swab Test Market Report Scope

Report Attribute Details
Market size in 2021 US$ 229.33 Million
Market Size by 2031 US$ 535.16 Million
Global CAGR (2023 - 2031) 9.2%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Type
  • Free ATP Test
  • Microbial ATP Test
By Application
  • Pharmaceutical and Biotechnology Companies
  • Food and Beverage
  • Hospitals and Diagnostics Laboratories
  • Academic and Research Institutions
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Hygiena, Llc
  • 3M
  • Charm Sciences, Inc.
  • Kikkoman Biochemifa
  • Neogen
  • Ecolab
  • Ruhof Healthcare Corporation
  • Luminultra Technologies Ltd.
  • Merck KgaA
  • Promega Corporation
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Adenosine Triphosphate (ATP) Swab Test Market News and Recent Developments

    The Adenosine Triphosphate (ATP) Swab Test Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Adenosine Triphosphate (ATP) Swab Test and strategies:

    • Ecolab Food and Beverage North America teamed up with Hygiena, LLC - a prominent company in the field of rapid food safety and environmental diagnostic testing technology. As a result of this partnership, the food and beverage industry will now have access to a new Hygiene Monitoring Program that can significantly help optimize their Food Safety programs. (Source: Adenosine Triphosphate (ATP) Swab Test Hygiena LLC, Press Release, 2020)

    Adenosine Triphosphate (ATP) Swab Test Market Report Coverage and Deliverables

    The “Adenosine Triphosphate (ATP) Swab Test Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Type, Application, End User

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Australia, Canada, China, France, Germany, India, Italy, Japan, Mexico, South Korea, Spain, United Kingdom, United States

    Trends and growth analysis reports related to Medical Device : READ MORE..